Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

R&D Expenses

$1.63B

Quarterly · Period ending: Jun 30, 2026 · USD

REGN R&D Expenses

Latest reported$1.63Bperiod endingJun 30, 2026

Latest reported$1.63Bperiod endingJun 30, 2026

REGN Quarterly R&D Expenses ($0.00 → $1.63B)

Quarterly R&D Expenses

High-resolution chart · PNG

REGN r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	19,596,000
Mar 31, 2001	16,805,000
Dec 31, 2000	15,786,000
Sep 30, 2000	14,085,000
Jun 30, 2000	14,410,000
Mar 31, 2000	11,975,000
Dec 31, 1999	9,900,000
Sep 30, 1999	12,900,000
Jun 30, 1999	10,800,000
Mar 31, 1999	11,200,000
Dec 31, 1998	9,900,000
Sep 30, 1998	9,900,000
Jun 30, 1998	9,100,000
Mar 31, 1998	8,200,000
Dec 31, 1997	7,000,000
Sep 30, 1997	6,800,000
Jun 30, 1997	6,900,000
Mar 31, 1997	7,100,000
Dec 31, 1996	6,900,000
Sep 30, 1996	7,700,000
Jun 30, 1996	6,800,000
Mar 31, 1996	6,900,000
Dec 31, 1995	6,000,000
Sep 30, 1995	5,700,000
Jun 30, 1995	5,800,000
Mar 31, 1995	5,800,000
Dec 31, 1994	9,100,000
Sep 30, 1994	9,500,000
Jun 30, 1994	10,300,000
Mar 31, 1994	10,800,000
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.